Atlas Trials

Stem Cell Monitoring for CML Patients Undergoing Nilotinib Therapy

Clinical trial NCT02353728 · COMPLETED

Trial details

NCT number
NCT02353728
Sponsor
Weill Medical College of Cornell University
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Chronic Myeloid Leukemia
Start date
2015-01-01
Primary completion
2021-02-01
Enrollment
16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.